April 29, 2020 / 8:10 PM / a month ago

BRIEF-Vertex Reports First-Quarter 2020 Financial Results

April 29 (Reuters) - Vertex Pharmaceuticals Inc:

* VERTEX REPORTS FIRST-QUARTER 2020 FINANCIAL RESULTS

* QTRLY EARNINGS PER SHARE $2.29

* QTRLY PRODUCT REVENUES, NET $1,515 MILLION VERSUS $857 MILLION

* QTRLY ADJUSTED EARNINGS PER SHARE $2.56

* CO RAISES REVENUE GUIDANCE; NOW EXPECTS 2020 CF REVENUES OF $5.3 TO $5.6 BILLION

* QTRLY TOTAL REVENUES $1.52 BILLION VERSUS $858.44 MILLION

* VERTEX PHARMACEUTICALS - GLOBAL COVID-19 OUTBREAK HAS NOT HAD ANY IMPACT ON THE CONTINUITY OF VERTEX’S SUPPLY CHAIN FOR ITS APPROVED MEDICINES

* Q1 EARNINGS PER SHARE VIEW $1.85, REVENUE VIEW $1.29 BILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below